Paper8617293
TAP1-deficient mice select a CD8+ T cell repertoire that displays both diversity and peptide specificity.
Sandberg JK and 4 others. Eur J Immunol, 1996. Cited by 40 papers, by iCite.
Cite this record
ConductScience Library. TAP1-deficient mice select a CD8+ T cell repertoire that displays both diversity and peptide specificity. Papers, record 8617293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8617293
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- TAP1-deficient mice select a CD8+ T cell repertoire that displays both diversity and peptide specificity.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| ATP-Binding Cassette Transporters | Major topic |
| CD8-Positive T-Lymphocytes | Major topic |
| ATP Binding Cassette Transporter, Subfamily B, Member 2 | |
| Amino Acid Sequence | |
| Animals | |
| Cytotoxicity, Immunologic | |
| Dose-Response Relationship, Immunologic | |
| Epitopes | |
| H-2 Antigens | |
| Immunophenotyping | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Mutant Strains | |
| Molecular Sequence Data | |
| T-Lymphocytes, Cytotoxic |
Source PubMed
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33767702 | Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation. | Front Immunol | 2021 | https://conductscience.org/library/papers/33767702 | PubMed |
| 27861817 | A novel spontaneous mutation in the TAP2 gene unravels its role in macrophage survival. | Immunology | 2017 | https://conductscience.org/library/papers/27861817 | PubMed |
| 27634283 | Improved Transgenic Mouse Model for Studying HLA Class I Antigen Presentation. | Sci Rep | 2016 | https://conductscience.org/library/papers/27634283 | PubMed |
| 26097483 | Alternative Antigen Processing for MHC Class I: Multiple Roads Lead to Rome. | Front Immunol | 2015 | https://conductscience.org/library/papers/26097483 | PubMed |
| 23240042 | Mobilization of regulatory T cells in response to carotid injury does not influence subsequent neointima formation. | PLoS One | 2012 | https://conductscience.org/library/papers/23240042 | PubMed |
| 22479479 | TAP1-deficiency does not alter atherosclerosis development in Apoe-/- mice. | PLoS One | 2012 | https://conductscience.org/library/papers/22479479 | PubMed |
| 19892989 | A single peptide-MHC complex positively selects a diverse and specific CD8 T cell repertoire. | Science | 2009 | https://conductscience.org/library/papers/19892989 | PubMed |
| 16895555 | TAP1-/- mice present oligoclonal BV-BJ expansions following the rejection of grafts bearing self antigens. | Immunology | 2006 | https://conductscience.org/library/papers/16895555 | PubMed |
| 16011517 | Autoreactivity to self H-2Kb peptides in TAP1 mice. Intravenous administration of H-2Kb class I-derived peptides induces long-term survival of grafts from C57BL/6 donors. | Immunology | 2005 | https://conductscience.org/library/papers/16011517 | PubMed |
| 11390439 | Immunoproteasomes shape immunodominance hierarchies of antiviral CD8(+) T cells at the levels of T cell repertoire and presentation of viral antigens. | J Exp Med | 2001 | https://conductscience.org/library/papers/11390439 | PubMed |
| 11122254 | MHC class I pathway is not required for the development of crescentic glomerulonephritis in mice. | Clin Exp Immunol | 2000 | https://conductscience.org/library/papers/11122254 | PubMed |
| 10973281 | Impaired immune responses and altered peptide repertoire in tapasin-deficient mice. | Nat Immunol | 2000 | https://conductscience.org/library/papers/10973281 | PubMed |
| 10729170 | Naturally occurring TAP-dependent specific T-cell tolerance for a variant of an immunodominant retroviral cytotoxic T-lymphocyte epitope. | J Virol | 2000 | https://conductscience.org/library/papers/10729170 | PubMed |
| 10075972 | Recognition of the major histocompatibility complex restriction element modulates CD8(+) T cell specificity and compensates for loss of T cell receptor contacts with the specific peptide. | J Exp Med | 1999 | https://conductscience.org/library/papers/10075972 | PubMed |
| 9826368 | Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissue. | Infect Immun | 1998 | https://conductscience.org/library/papers/9826368 | PubMed |
| 9770513 | Major histocompatibility complex (MHC) class I KbDb -/- deficient mice possess functional CD8+ T cells and natural killer cells. | Proc Natl Acad Sci U S A | 1998 | https://conductscience.org/library/papers/9770513 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TAP1 | 6890 | PubTator's text mining | https://conductscience.org/library/genes/6890 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8617293
GET https://conductscience.org/api/papers/v1/8617293/authors